Beijing Tide Pharmaceutical Co., Ltd

This study tests an experimental drug called TDI01 in 60 adults with moderate or severe chronic graft-versus-host disease (GVHD) after a stem cell transplant. Participants must have tried 1 to 5 other treatments without success. The goal is to see if TDI01 can control the disease…